Paper7654491
Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.
Vree TB and 2 others. Br J Clin Pharmacol, 1995. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide. Papers, record 7654491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654491
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Furosemide | Major topic |
| Glucuronates | Major topic |
| Kidney | Major topic |
| Probenecid | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Binding Sites | |
| Cross-Over Studies | |
| Drug Interactions | |
| Female | |
| Humans | |
| Male |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1233253 | On the fate of furosemide in man. | Eur J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1233253 | PubMed |
| 2 | 8061834 | Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid. | J Chromatogr B Biomed Appl | 1994 | https://conductscience.org/library/papers/8061834 | PubMed |
| 3 | 699479 | Effects of probenecid on furosemide response. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/699479 | PubMed |
| 4 | 458552 | Pharmacokinetics/pharmacodynamics of furosemide in man: a review. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/458552 | PubMed |
| 5 | 513505 | Pharmacodynamic analysis of the furosemide-probenecid interaction in man. | Kidney Int | 1979 | https://conductscience.org/library/papers/513505 | PubMed |
| 6 | 7381747 | Preliminary evaluation of furosemide-probenecid interaction in humans. | J Pharm Sci | 1980 | https://conductscience.org/library/papers/7381747 | PubMed |
| 7 | 6107232 | Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. | Drug Metab Dispos | 1980 | https://conductscience.org/library/papers/6107232 | PubMed |
| 8 | 7452492 | Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. | J Pharmacol Exp Ther | 1980 | https://conductscience.org/library/papers/7452492 | PubMed |
| 9 | 6339277 | Furosemide assays and disposition in healthy volunteers and renal transplant patients. | Fed Proc | 1983 | https://conductscience.org/library/papers/6339277 | PubMed |
| 10 | 6350024 | Biotransformation of furosemide in kidney transplant patients. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6350024 | PubMed |
| 11 | 6396057 | Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. | Drug Metab Rev | 1984 | https://conductscience.org/library/papers/6396057 | PubMed |
| 12 | 2867875 | Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms. | Drug Metab Dispos | 1985 | https://conductscience.org/library/papers/2867875 | PubMed |
| 13 | 2654356 | Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update. | J Pharmacokinet Biopharm | 1989 | https://conductscience.org/library/papers/2654356 | PubMed |
| 14 | 2185908 | Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2185908 | PubMed |
| 15 | 1617949 | MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. | Comput Biol Med | 1992 | https://conductscience.org/library/papers/1617949 | PubMed |
| 16 | 1630876 | Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1630876 | PubMed |
| 17 | 1437517 | Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study. | Pharm Weekbl Sci | 1992 | https://conductscience.org/library/papers/1437517 | PubMed |
| 18 | 8512758 | The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8512758 | PubMed |
| 19 | 8220301 | Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment. | Pharm World Sci | 1993 | https://conductscience.org/library/papers/8220301 | PubMed |
| 20 | 8156046 | Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment. | Pharm World Sci | 1994 | https://conductscience.org/library/papers/8156046 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39994867 | Pyridoxic Acid as Endogenous Biomarker of Renal Organic Anion Transporter Activity: Population Variability and Mechanistic Modeling to Predict Drug-Drug Interactions. | CPT Pharmacometrics Syst Pharmacol | 2025 | https://conductscience.org/library/papers/39994867 | PubMed |
| 37896187 | The Impact of Inflammation on the In Vivo Activity of the Renal Transporters OAT1/3 in Pregnant Women Diagnosed with Acute Pyelonephritis. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896187 | PubMed |
| 37866801 | Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers. | Biochem Pharmacol | 2023 | https://conductscience.org/library/papers/37866801 | PubMed |
| 36769175 | Kidney Drug Transporters in Pharmacotherapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769175 | PubMed |
| 33403255 | Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide. | ACS Omega | 2020 | https://conductscience.org/library/papers/33403255 | PubMed |
| 33237382 | Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions. | Pharm Res | 2020 | https://conductscience.org/library/papers/33237382 | PubMed |
| 33062845 | Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing. | Transplant Direct | 2020 | https://conductscience.org/library/papers/33062845 | PubMed |
| 32504272 | Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine. | Clin Pharmacokinet | 2020 | https://conductscience.org/library/papers/32504272 | PubMed |
| 31675437 | Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure Prophylaxis. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31675437 | PubMed |
| 29627897 | Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters. | Eur J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/29627897 | PubMed |
| 28749581 | Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib. | Clin Transl Sci | 2017 | https://conductscience.org/library/papers/28749581 | PubMed |
| 27709005 | Renal drug transporters and their significance in drug-drug interactions. | Acta Pharm Sin B | 2016 | https://conductscience.org/library/papers/27709005 | PubMed |
| 25972096 | Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions. | Pharm Res | 2015 | https://conductscience.org/library/papers/25972096 | PubMed |
| 23649425 | Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). | J Pharm Sci | 2013 | https://conductscience.org/library/papers/23649425 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7654491
GET https://conductscience.org/api/papers/v1/7654491/references?page=2